FDA Approved: TRI-LEGEST FE 28 DAY — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved the generic oral contraceptive Tri-Legest FE 28 Day (norethindrone acetate and ethinyl estradiol) via an original ANDA for pregnancy prevention…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Prevention

Drugs mentioned

• TRI-LEGEST FE 28 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for TRI-LEGEST FE 28 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)